| We actively represent patient interests before healthcare regulators and the National Health Basket Committee of Israel. | 호흡기
> 천식 및 COPD | 규제 파트너십
> 규제 기관과의 협력 | We do not communicate with patients directly | National | Regularly | 119068242117 |
| We actively represent patient interests before healthcare regulators and the National Health Basket Committee of Israel. | 호흡기
> 천식 및 COPD | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | We do not communicate with patients directly | National | Regularly | 119068242117 |
| We have influence over the drugs included in the basket of medicines that receive regulatory pricing. This is an annual process to which we are able to contribute. | 자가면역
> 자가면역: 대부분의 유형 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 5,000 | National | Sometimes | 119068245670 |
| We are applying to the Health office about including IVIG [Intravenous Immunoglobulin] as an indication to treat Myasthenia Gravis. | 신경근
> 중증 근무력증 | 규제 파트너십
> 건강기술평가(HTA) 및 급여 검토에 참여 | 1,000 | National | Sometimes | 119074555668 |
| Raising awareness for drug technologies, helping new drugs to be approved by government, etc. | 환자 권익 옹호
> 약물 및 관련 치료 | 규제 파트너십
> 마케팅 허가 제출에 기여 | 5,000 | National | Regularly | 119062572474 |
| Once a year, we submit our support to the National Health Basket Committee of Israel. We talk regularly with the regulators, but not on drug pricing. | 이식
> 이식: 심장 및 폐 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 100,000 | National | Rarely | 119058027478 |
| ... We talk regularly with the regulators, but not on drug pricing. | 이식
> 이식: 심장 및 폐 | 규제 파트너십
> 정책 입안자/규제 기관과의 회의 참석/진행 | 100,000 | National | Rarely | 119058027478 |
| Changing laws. | 일반 건강
> 성 건강: 기타 | 정책 및 법률에 영향 미치기
> 의료 정책 및 법률에 영향력 행사 | 5,000 | National | Regularly | 119020325100 |
| Our organisation raises patient needs related to access to treatments and affordability through collaborations, policy discussions, and engagement with stakeholders in the healthcare system. | 환자 권익 옹호
> 환자 권익 옹호 | 정책 및 법률에 영향 미치기
> 의료 정책 및 법률에 영향력 행사 | 10,000 | National | Sometimes | 119084033692 |
| In government committees, in submitting position papers, etc. | 환자 권익 옹호
> 약물 및 관련 치료 | 정책 및 법률에 영향 미치기
> 공청회 및 협의에 참여하기 | 5,000 | National | Sometimes | 119025692602 |
| We are applying to the Health office about including IVIG [Intravenous Immunoglobulin] as an indication to treat Myasthenia Gravis. | 신경근
> 중증 근무력증 | 정책 및 법률에 영향 미치기
> 의료 서비스의 장벽/이상 현상 해결 | 1,000 | National | Sometimes | 119074555668 |
| An attempt to lower the price of a certain drug so that it will be included in the public drug basket in Israel. | 암
> 암: 전립선 | 가격 책정 및 affordability 옹호
> 공정한 의약품 가격 책정 옹호 | 10,000 | National | Rarely | 119065366296 |
| We actively represent patient interests before healthcare regulators and the National Health Basket Committee. We advocate for the inclusion of essential treatments and medications in the national reimbursement list, ensuring that patient needs are prioritised in pricing and accessibility decisions. | 호흡기
> 천식 및 COPD | 가격 책정 및 affordability 옹호
> 공정한 의약품 가격 책정 옹호 | We do not communicate with patients directly | National | Regularly | 119068242117 |
| Our organisation raises patient needs related to access to treatments and affordability through collaborations, policy discussions, and engagement with stakeholders in the healthcare system. | 환자 권익 옹호
> 환자 권익 옹호 | 가격 책정 및 affordability 옹호
> 공정한 의약품 가격 책정 옹호 | 10,000 | National | Sometimes | 119084033692 |
| We have influence over the drugs included in the basket of medicines that receive regulatory pricing. This is an annual process to which we are able to contribute. | 자가면역
> 자가면역: 대부분의 유형 | 가격 책정 및 affordability 옹호
> 가격 검토 위원회 협상에 참여 | 5,000 | National | Sometimes | 119068245670 |
| An attempt to lower the price of a certain drug so that it will be included in the public drug basket in Israel. | 암
> 암: 전립선 | 가격 책정 및 affordability 옹호
> 제품의 급여 목록/국가 처방집 등재 옹호 | 10,000 | National | Rarely | 119065366296 |
| We advocate for the inclusion of essential treatments and medications in the national reimbursement list, ensuring that patient needs are prioritised in pricing and accessibility decisions. | 호흡기
> 천식 및 COPD | 가격 책정 및 affordability 옹호
> 제품의 급여 목록/국가 처방집 등재 옹호 | We do not communicate with patients directly | National | Regularly | 119068242117 |
| Our organisation raises patient needs, related to access to treatments and affordability through collaborations, policy discussions, and engagement with stakeholders in the healthcare system. | 환자 권익 옹호
> 환자 권익 옹호 | 접근 경로 개선
> 의약품/의료서비스에 대한 공평한 접근 촉진 | 10,000 | National | Sometimes | 119084033692 |
| In government committees, in submitting position papers, etc. | 환자 권익 옹호
> 약물 및 관련 치료 | 기관 거버넌스
> 정부 자문 기구 내 대표성 확보 | 5,000 | National | Sometimes | 119025692602 |
| We actively represent patient interests before healthcare regulators and the National Health Basket Committee of Israel. | 호흡기
> 천식 및 COPD | 기관 거버넌스
> 정부 자문 기구 내 대표성 확보 | We do not communicate with patients directly | National | Regularly | 119068242117 |
| Workplaces that do not give the patient permission to see the doctor at the right time. | 일반 건강
> 성 건강: 기타 | 환자 권리 보호/삶의 질 향상
> 환자 경험 보호/개선 | 5,000 | National | Regularly | 119035841801 |
상호작용
활동 및 옹호
6 멘션
